Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysisJi Y. Son, David S. Hong, Amir A. Jazaeri et al.|Gynecologic Oncology|2022Cited by 20
EON: Phase II trial of etigilimab (MPH313) in combination with nivolumab in patients with recurrent platinum-resistant clear cell ovarian cancer.Ji Y. Son, Shannon N. Westin, Emily Hinchcliff et al.|Journal of Clinical Oncology|2025Cited by 1